oxazolidin-2-one has been researched along with Listeria Cerebritis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Manfredi, R | 1 |
Bongiorno, D; Campanile, F; Di Nucci, GD; Pistella, E; Serra, P; Stefani, S; Venditti, M | 1 |
Chiodo, F; Manfredi, R; Marinacci, G; Sabbatani, S; Salizzoni, E | 1 |
3 other study(ies) available for oxazolidin-2-one and Listeria Cerebritis
Article | Year |
---|---|
Linezolid activity against disseminated Listeria monocytogenes meningitis and central nervous system abscesses: focus on early drug myelotoxicity.
Topics: Acetamides; Anemia; Anti-Infective Agents; Brain Abscess; Brain Stem; Cerebellar Diseases; Humans; Immunocompetence; Linezolid; Magnetic Resonance Imaging; Male; Meningitis, Listeria; Meropenem; Middle Aged; Oxazolidinones; Thienamycins; Tomography, X-Ray Computed | 2007 |
Successful treatment of disseminated cerebritis complicating methicillin-resistant Staphylococcus aureus Endocarditis unresponsive to vancomycin therapy with linezolid.
Topics: Acetamides; Bacteremia; Community-Acquired Infections; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Endocarditis, Bacterial; Follow-Up Studies; Humans; Infusions, Intravenous; Linezolid; Male; Meningitis, Listeria; Methicillin Resistance; Middle Aged; Oxazolidinones; Risk Assessment; Severity of Illness Index; Staphylococcal Infections; Tomography, X-Ray Computed; Treatment Outcome; Vancomycin | 2004 |
Listeria monocytogenes meningitis and multiple brain abscesses in an immunocompetent host. Favorable response to combination linezolid-meropenem treatment.
Topics: Acetamides; Anemia; Anti-Bacterial Agents; Brain Abscess; Drug Therapy, Combination; Humans; Immunocompetence; Linezolid; Male; Meningitis, Listeria; Meropenem; Middle Aged; Oxazolidinones; Thienamycins | 2006 |